Opportunity Radar

← Back to search

Grant

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
G
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
RFA-NS-25-023
Posted
Sep 18, 2024
Response due
Jan 15, 2027
Archive date
Feb 20, 2027
CFDA / Assistance listing
93.121,93.213,93.273,93.393,93.846,93.847,93.853,93.865,93.866,93.867
Award ceiling
$350,000
Contact
grantsinfo@nih.gov
Source
Grants.gov

Description

This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).

Similar open opportunities